Editorial & Opinion

Anti-tumour necrosis factor-associated cutaneous leishmaniasis: a single-institution experience.

التفاصيل البيبلوغرافية
العنوان: Anti-tumour necrosis factor-associated cutaneous leishmaniasis: a single-institution experience.
المؤلفون: Martínez-Doménech A; Department of Dermatology, Hospital General Universitario de Valencia, Avenida Tres Cruces 2, 46014, Valencia, Spain., García-Legaz-Martínez M; Department of Dermatology, Hospital General Universitario de Valencia, Avenida Tres Cruces 2, 46014, Valencia, Spain., Magdaleno-Tapial J; Department of Dermatology, Hospital General Universitario de Valencia, Avenida Tres Cruces 2, 46014, Valencia, Spain., Torrecillas M; Department of Microbiology, Hospital General Universitario de Valencia, Avenida Tres Cruces 2, 46014, Valencia, Spain., Hernández-Bel P; Department of Dermatology, Hospital General Universitario de Valencia, Avenida Tres Cruces 2, 46014, Valencia, Spain., Ocete Mochón MD; Department of Microbiology, Hospital General Universitario de Valencia, Avenida Tres Cruces 2, 46014, Valencia, Spain., Pérez-Ferriols A; Department of Dermatology, Hospital General Universitario de Valencia, Avenida Tres Cruces 2, 46014, Valencia, Spain., de Miquel VA; Department of Dermatology, Hospital General Universitario de Valencia, Avenida Tres Cruces 2, 46014, Valencia, Spain.
المصدر: The British journal of dermatology [Br J Dermatol] 2019 Aug; Vol. 181 (2), pp. 403-405. Date of Electronic Publication: 2019 May 06.
نوع المنشور: Letter
اللغة: English
بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE
أسماء مطبوعة: Publication: 2023- : Oxford : Oxford University Press
Original Publication: Oxford [etc.] Published for the British Association of Dermatologists by Blackwell Scientific Publications [etc.]
مواضيع طبية MeSH: Immunosuppressive Agents/*adverse effects , Leishmaniasis, Cutaneous/*diagnosis , Tumor Necrosis Factor-alpha/*antagonists & inhibitors, Adult ; Aged ; DNA, Protozoan/isolation & purification ; Female ; Humans ; Leishmania donovani/genetics ; Leishmania donovani/isolation & purification ; Leishmania infantum/genetics ; Leishmania infantum/isolation & purification ; Leishmaniasis, Cutaneous/immunology ; Leishmaniasis, Cutaneous/parasitology ; Leishmaniasis, Cutaneous/pathology ; Male ; Middle Aged ; Skin/parasitology ; Skin/pathology ; Tumor Necrosis Factor-alpha/immunology ; Young Adult
المشرفين على المادة: 0 (DNA, Protozoan)
0 (Immunosuppressive Agents)
0 (TNF protein, human)
0 (Tumor Necrosis Factor-alpha)
تواريخ الأحداث: Date Created: 20190120 Date Completed: 20200930 Latest Revision: 20200930
رمز التحديث: 20231215
DOI: 10.1111/bjd.17644
PMID: 30659588
قاعدة البيانات: MEDLINE
الوصف
تدمد:1365-2133
DOI:10.1111/bjd.17644